COLL
COLLEGIUM PHARMACEUTICAL, INCCompany Information
- Company Name
- COLLEGIUM PHARMACEUTICAL, INC
- CIK
- CIK0001267565
- Category
- Large accelerated filer
- Ticker: Exchange
- COLL: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2834
- SIC Description
- Pharmaceutical Preparations
- Ticker
- COLL
SEC filing data through
Insider Sentiment
- Last purchase
- —
- Last sale
- 2026-05-18
- Shares purchased (TTM)
- 0
- Shares sold (TTM)
- 261,019
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 38,608,584
- Shares outstanding
- 32,460,783
- Ownership
- 118.94%
Earnings Market Reaction
- Filing date
- 2026-08-06
- Price on filing date
- —
- 1-month reaction
- -12.92%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 129 | 269 | 231 | 150 | 117 | 96 | 71 | 39 | 173 | 229 | 239 | 259 | ||||||
| Marketable Securities Current | 0 | 153 | 155 | 136 | 105 | 102 | 92 | 81 | 99 | 89 | 72 | 46 | ||||||
| Accounts Receivable Net Current | 285 | 229 | 211 | 234 | 213 | 229 | 229 | 228 | 184 | 175 | 180 | 182 | ||||||
| Inventory Net | 113 | 43 | 41 | 38 | 38 | 37 | 36 | 38 | 28 | 31 | 32 | 34 | ||||||
| Prepaid Expense And Other Assets Current | 60 | 33 | 33 | 36 | 56 | 44 | 30 | 32 | 27 | 15 | 15 | 17 | ||||||
| Restricted Cash Current | 20 | 20 | 20 | 20 | 20 | 20 | 25 | 25 | - | - | - | - | ||||||
| Assets Current | 608 | 746 | 691 | 614 | 549 | 528 | 482 | 444 | 510 | 539 | 538 | 537 | ||||||
| Property Plant And Equipment Net | 11 | 12 | 12 | 12 | 13 | 14 | 14 | 15 | 15 | 15 | 16 | 17 | ||||||
| Operating Lease Right Of Use Asset | 4 | 4 | 4 | 4 | 5 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | ||||||
| Intangible Assets Net Excluding Goodwill | 1,186 | 614 | 670 | 725 | 780 | 836 | 891 | 947 | 353 | 387 | 422 | 456 | ||||||
| Restricted Cash And Cash Equivalents Noncurrent | - | - | - | - | - | - | - | - | 1 | 1 | 1 | 1 | ||||||
| Restricted Cash Noncurrent | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | - | - | 1 | - | ||||||
| Deferred Income Tax Assets Net | 121 | 114 | 113 | 102 | 92 | 92 | 98 | 73 | 34 | 31 | 26 | 26 | ||||||
| Other Assets Noncurrent | 15 | 16 | 20 | 2 | 4 | 5 | 8 | 4 | 1 | 1 | 1 | 1 | ||||||
| Goodwill | 190 | 146 | 146 | 146 | 148 | 151 | 162 | 146 | 134 | 134 | 134 | 134 | ||||||
| Assets | 2,136 | 1,652 | 1,657 | 1,607 | 1,593 | 1,631 | 1,664 | 1,635 | 1,053 | 1,114 | 1,143 | 1,178 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable Current | 9 | 7 | 11 | 8 | 11 | 18 | 4 | 3 | 2 | 6 | 9 | 4 | ||||||
| Accrued Liabilities Current | 71 | 58 | 62 | 51 | 59 | 54 | 72 | 48 | 39 | 38 | 38 | 32 | ||||||
| Loans Payable Current | 55 | 33 | 29 | 65 | 65 | 65 | 65 | 65 | 183 | 183 | 183 | 183 | ||||||
| Operating Lease Liability Current | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Business Combination Contingent Consideration Liability Current | 16 | 18 | 18 | 0 | 0 | 25 | 29 | 29 | - | - | - | - | ||||||
| Contract With Customer Liability Current | 1 | 1 | 1 | 1 | - | - | 0 | - | - | - | - | - | ||||||
| Liabilities Current | 590 | 435 | 440 | 453 | 465 | 487 | 510 | 459 | 462 | 446 | 458 | 465 | ||||||
| Long Term Loans Payable | 798 | 532 | 542 | 506 | 521 | 536 | 551 | 566 | 133 | 177 | 222 | 266 | ||||||
| Convertible Long Term Notes Payable | 239 | 238 | 238 | 238 | 238 | 237 | 237 | 237 | 237 | 262 | 262 | 262 | ||||||
| Operating Lease Liability Noncurrent | 3 | 4 | 4 | 5 | 5 | 5 | 6 | 6 | 6 | 6 | 6 | 6 | ||||||
| Contract With Customer Liability Noncurrent | 9 | 9 | 9 | 9 | 10 | 10 | 10 | 10 | - | - | - | - | ||||||
| Business Combination Contingent Consideration Liability Noncurrent | 23 | - | 0 | - | - | 0 | 1 | 4 | - | - | - | - | ||||||
| Deferred Income Tax Liabilities Net | 41 | - | - | - | - | - | - | - | - | - | - | - | ||||||
| Liabilities | 1,824 | 1,340 | 1,355 | 1,333 | 1,360 | 1,397 | 1,435 | 1,401 | 837 | 892 | 948 | 999 | ||||||
Stockholders Equity | ||||||||||||||||||
| Preferred Stock Value | 0 | 0 | 0 | - | - | - | 0 | - | - | - | - | - | ||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital | 636 | 622 | 625 | 615 | 599 | 593 | 590 | 583 | 568 | 565 | 566 | 546 | ||||||
| Treasury Stock Common Value | -223 | -223 | -223 | -223 | -218 | -198 | -198 | -172 | -165 | -137 | -137 | -102 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | 0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 | -0 | 0 | -0 | ||||||
| Retained Earnings Accumulated Deficit | -102 | -87 | -101 | -118 | -150 | -162 | -164 | -177 | -186 | -205 | -233 | -265 | ||||||
| Stockholders Equity | 312 | 312 | 302 | 275 | 232 | 234 | 229 | 234 | 217 | 222 | 195 | 179 | ||||||
| Liabilities And Stockholders Equity | 2,136 | 1,652 | 1,657 | 1,607 | 1,593 | 1,631 | 1,664 | 1,635 | 1,053 | 1,114 | 1,143 | 1,178 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Authorized | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | ||||||
| Common Stock Shares Issued | 42 | 41 | 41 | 41 | 40 | 40 | 40 | 40 | 40 | 39 | 38 | 38 | ||||||
| Shares Outstanding | 32 | 32 | 32 | 32 | 32 | 32 | 31 | 32 | 32 | 33 | 32 | 33 | ||||||
| Treasury Stock Common Shares | 9 | 9 | 9 | 9 | 9 | 8 | 8 | 7 | 7 | 6 | 6 | 5 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialCOLLEGIUM PHARMACEUTICAL, INC (COLL) — SEC Financial Statements & Analysis
COLLEGIUM PHARMACEUTICAL, INC (COLL) is a pharmaceutical preparations company, incorporated in VA. COLLEGIUM PHARMACEUTICAL, INC trades on Nasdaq as: COLL. COLLEGIUM PHARMACEUTICAL, INC (COLL)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-06. Based on that filing, COLLEGIUM PHARMACEUTICAL, INC carries a market cap of $1.18B, a P/E ratio of 24.52x, a P/B ratio of 3.77x, a P/S ratio of 1.45x, an enterprise value of $1.32B, and an EV/EBITDA multiple of 8.16x. On profitability, it posts a gross margin of 60.02%, an operating margin of 19.48%, a net margin of 5.93%, a Return on Equity (ROE) of 17.61%, a Return on Assets (ROA) of 2.57%, and a Return on Invested Capital (ROIC) of 22.03%. Per share, it reports EPS of $1.48, diluted EPS of $1.48, free cash flow per share of $10.11, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of 14.31% year-over-year, net income growth of 32.10% year-over-year, and EPS growth of 29.46% year-over-year. On the balance sheet, it maintains a current ratio of 1.03x, a quick ratio of 0.74x, working capital of $18.15M, a debt-to-equity ratio of 5.85x, a debt ratio of 0.85, an interest coverage ratio of 2.06x, free cash flow of $328.28M (TTM), and net debt of $143.36M. Figures sourced from SEC EDGAR.
- Market Cap
- $1.18B
- P/E TTM
- 24.52x
- EPS TTM
- $1.48
- P/B TTM
- 3.77x
- ROE TTM
- 17.61%
- ROA TTM
- 2.57%
- Debt To Equity
- 5.85x
- Free Cash Flow TTM
- $328.28M
- Net Revenue TTM Growth 1Y
- 14.31%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is COLLEGIUM PHARMACEUTICAL, INC in?
COLLEGIUM PHARMACEUTICAL, INC (COLL) operates in the Pharmaceutical Preparations industry.
What exchange does COLL trade on?
COLLEGIUM PHARMACEUTICAL, INC (COLL) trades on the Nasdaq.
Where is COLLEGIUM PHARMACEUTICAL, INC incorporated?
COLLEGIUM PHARMACEUTICAL, INC is incorporated in VA.
When was COLLEGIUM PHARMACEUTICAL, INC (COLL)'s most recent SEC filing?
COLLEGIUM PHARMACEUTICAL, INC (COLL)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-06.
What is COLL's market cap?
COLLEGIUM PHARMACEUTICAL, INC (COLL) has a market capitalization of $1.18B as of 2026-06-30.
What is COLL's P/E ratio?
COLLEGIUM PHARMACEUTICAL, INC (COLL)'s trailing twelve month P/E ratio is 24.52x as of 2026-06-30.
What is COLL's EPS (earnings per share)?
COLLEGIUM PHARMACEUTICAL, INC (COLL)'s trailing twelve month EPS is $1.48 as of 2026-06-30.
What is COLL's ROE (return on equity)?
COLLEGIUM PHARMACEUTICAL, INC (COLL)'s trailing twelve month Return on Equity (ROE) is 17.61% as of 2026-06-30.
What is COLL's ROA (return on assets)?
COLLEGIUM PHARMACEUTICAL, INC (COLL)'s trailing twelve month Return on Assets (ROA) is 2.57% as of 2026-06-30.
What is COLL's ROIC (return on invested capital)?
COLLEGIUM PHARMACEUTICAL, INC (COLL)'s trailing twelve month Return on Invested Capital (ROIC) is 22.03% as of 2026-06-30.
What is COLL's EV/EBITDA?
COLLEGIUM PHARMACEUTICAL, INC (COLL)'s trailing twelve month EV/EBITDA is 8.16x as of 2026-06-30.